Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020)
Alterity Therapeutics' quarterly Exchange Rate Effect came in at -$172360.6 in Q2 2020, up 39.07% year-on-year from -$123933.5 in Q3 2019, and down 297.37% quarter-over-quarter from $87328.6 in Q4 2019.
Alterity Therapeutics has reported Exchange Rate Effect for 5 years, with the latest figure at -$172360.6 in Q2 2020.
- For the quarter ending Q2 2020, Exchange Rate Effect rose 39.07% year-over-year to -$172360.6; the trailing twelve-month figure through Jun 2020 stood at -$203082.4 (up 65.29% YoY), and the FY2025 full-year result was -$127045.9, down 174.04% from the prior year.
- Exchange Rate Effect for Q2 2020 stood at -$172360.6, down from $87328.6 in the prior quarter.
- The five-year high for Exchange Rate Effect was $409359.2 in Q4 2016, with the low at -$709904.9 in Q2 2016.
- Average Exchange Rate Effect over 5 years is -$121323.2, with a median of -$85127.6 recorded in 2018.
- Year-over-year, Exchange Rate Effect jumped 135.15% in 2018 and plunged 13536.85% in 2019.
- Tracing ATHE's Exchange Rate Effect over 5 years: stood at $409359.2 in 2016, then plunged by 214.58% to -$469062.8 in 2017, then jumped by 135.15% to $164855.6 in 2018, then tumbled by 47.03% to $87328.6 in 2019, then sank by 297.37% to -$172360.6 in 2020.
- The last three Exchange Rate Effect figures came in at -$172360.6 (Q2 2020), $87328.6 (Q4 2019), and -$282906.0 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -172,360.55 |
| Jun 30, 2020 | -172,360.55 |
| Dec 31, 2019 | 87,328.62 |
| Dec 31, 2019 | 87,328.62 |
| Jun 30, 2019 | -282,906.04 |
| Jun 30, 2019 | -282,906.04 |
| Dec 31, 2018 | 164,855.57 |
| Dec 31, 2018 | 164,855.57 |
| Jun 30, 2018 | 2,105.45 |
| Jun 30, 2018 | 2,105.45 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2016 | 409,359.19 |
| Dec 31, 2016 | 409,359.19 |
| Jun 30, 2016 | -709,904.92 |
| Jun 30, 2016 | -709,904.92 |